Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Christophe BAZIN"'
Autor:
Jean-Pierre BIDANEL, Parsaoran SILALAHI, Thierry TRIBOUT, Laurianne CANARIO, Alain DUCOS, Hervé GARREAU, Hélène GILBERT, Catherine LARZUL, Denis MILAN, Juliette RIQUET, Sandrine SCHWOB, Marie-José MERCAT, Claire HASSENFRATZ, Alain BOUQUET, Christophe BAZIN, Joel BIDANEL
Publikováno v:
INRAE Productions Animales, Vol 33, Iss 1 (2020)
Cette synthèse fait le point sur les principales évolutions de l’amélioration génétique du porc en France depuis la loi sur l’élevage de 1966. Elle évoque rapidement les 20 premières années, qui ont fait l’objet d’une synthèse en 19
Externí odkaz:
https://doaj.org/article/9633af15efda4b50bc5e5282069c0bf5
Autor:
Guillaume Dezecache, Aude Bourgeois, Christophe Bazin, Philippe Schlenker, Emmanuel Chemla, Audrey Maille
Publikováno v:
Animals, Vol 9, Iss 6, p 300 (2019)
Zoological institutions often encourage cooperative interactions between keepers and animals so as to promote animals’ welfare. One useful technique has been conditioning training, whereby animals learn to respond to keepers’ requests, which faci
Externí odkaz:
https://doaj.org/article/1f0f45aaa2694df080d132d340ee87bb
Autor:
Helena Pereira, Mohamed Bouattour, Marco D. Burgio, Eric Assenat, Jules Grégory, Jean-Pierre Bronowicki, Gilles Chatellier, Valérie Vilgrain, Elisabeth Delhom-Christol, Marjolène Fourcade, Boris Guiu, Alina Diana Ilonca, Julie Lonjon, Georges-Philippe Pageaux, Mohamed Abdel-Rehim, Wassim Allaham, Laurent Castera, Arnaud Dieudonné, Rachida Lebtahi, Maxime Ronot, Annie Sibert, Hélène Chor, Julie Devictor, Hélène Barraud, Christophe Bazin, Laetitia Imbert, Valérie Laurent, Elodie Mathias, Carine Chagneau-Derrode, Christelle Gallais, Rémy Perdrisot, Christine Silvain, Jean Pierre Tasu, Patrick Borentain, Bardia Farman, René Gerolami, Olivier Mundler, Jean-Francois Seitz, Vincent Vidal, Christophe Aubé, Francis Bouchet, Antoine Bouvier, Olivier Couturier, Frédéric Oberti, Laurent Vervueren, Isabelle Brenot-Rossi, Julien Darreon, Jean Luc Raoul, Anthony Sarran, Julia Chalaye, Charlotte Costentin, Emmanuel Itti, Hicham Kobeiter, Alain Luciani, Hélène Masset, René Adam, Maïté Lewin, Didier Samuel, Julien Edeline, Etienne Garin, Sophie Laffont, Yan Rolland, Isabelle Archambeaud, Thomas Carlier, Thomas Eugene, Eric Frampas, Christophe Cassinotto, Martine Guyot, Jean-Baptiste Hiriart, Bruno Lapuyade, Karine Tendero, Julien Vergniol, Philippe Bachellier, Julien Détour, Bernard Duclos, Michel Greget, Francois Habersetzer, Alessio Imperiale, Elise Enderlin, Philippe Merle, Agnès Rode, Julie Morvan, Eric Nguyen-Khac, Antoine Talbot, Thierry Yzet, Guillaume Baudin, Patrick Chevallier, Abakar Mahamat, Fabien Maurel, Thierry Piche, Micheline Razzouk, Patrick Hillon, Romaric Loffroy, Michel Toubeau, Julie Vincent, Jean-Marc Vrigneaud, Gabriele Barabino, Nadia Bouarioua, Muriel Cuilleron, Marie Ecochard, Nathalie Prevot-Bitot, Evelyne Rousset, Vincent Leroy, Ghislaine Reboulet, Julie Roux, Christian Sengel, Valérie Bourcier, Nathalie Ganne-Carrie, Olivier Seror, Sylvie Costo, Thông Dao, Cédric Desmonts, Jean-Pierre Pelage, Didier Defez, Jérôme Dumortier, Francesco Giammarile, Pierre-Jean Valette, Michela Bernardini, Nadia Ghazar, Olivier Pellerin, Julien Taieb, Pierre Weinmann, Alexandra Heurgue-Berlot, Claude Marcus, Daniele Sommacale, Maria-Angéla Castilla-Lièvre, Aurélie Forbes, Sophie Maitre, Lysiane Marthey
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2021, 154, pp.46-56. ⟨10.1016/j.ejca.2021.05.032⟩
European Journal of Cancer, Elsevier, 2021, 154, pp.46-56. ⟨10.1016/j.ejca.2021.05.032⟩
Background The aim of this ancillary study of the SARAH trial is to compare health-related quality of life (HRQoL) in patients with locally advanced or inoperable hepatocellular carcinoma (HCC) treated with transarterial radioembolisation (TARE) or s
Autor:
Kevin Zarca, Maroua Mimouni, Helena Pereira, Gilles Chatellier, Valérie Vilgrain, Isabelle Durand-Zaleski, Eric Assenat, Elisabeth Delhom-Christol, Boris Guiu, Alina D. Ilonca, Julie Lonjon, Georges-Philippe Pageaux, Mohamed Abdel-Rehim, Wassim Al-laham, Mohamed Bouattour, Laurent Castera, Arnaud Dieudonné, Rachida Lebtahi, Maxime Ronot, Annie Sibert, Hélène Barraud, Christophe Bazin, Jean-Pierre Bronowicki, Valérie Laurent, Elodie Mathias, Carine Chagneau-Derrode, Rémy Perdrisot, Christine Silvain, Jean-Pierre Tasu, Patrick Borentain RenéGerolami, Olivier Mundler, Jean-Francois Seitz, Vincent Vidal, Christophe Aubé, Antoine Bouvier, Olivier Couturier, Frédéric Oberti, Laurent Vervueren, Isabelle Brenot-Rossi, Jean-Luc Raoul, Anthony Sar-ran, Julia Chalaye, Charlotte Costentin, Emmanuel Itti, Hicham Kobeiter, Alain Luciani, René Adam, Maïté Lewin, Didier Samuel, Julien Edeline, Etienne Garin, Yan Rolland, Isabelle Archambeaud, Thomas Eugene, Eric Frampas, Christophe Cassinotto, Martine Guyot, Jean-Baptiste Hiriart, Bruno Lapuyade, Julien Vergniol, Philippe Bachellier, Julien Detour, Bernard Duclos, Michel Greget, Francois Habersetzer, Alessio Imperiale, Philippe Merle, Agnès Rode, Julie Morvan, Eric Nguyen-Khac, Thierry Yzet, Guillaume Baudin, Patrick Chevallier, Abakar Mahamat, Thierry Piche, Micheline Razzouk, Patrick Hillon, Romaric Loffroy, Michel Toubeau, Julie Vincent, Gabriele Barabino, Nadia Bouarioua, Muriel Cuilleron, Marie Ecochard, Nathalie Prevot-Bitot, Vincent Leroy, Julie Roux, Christian Sengel, Valérie Bourcier, Nathalie Ganne- Carrie, Olivier Seror, Sylvie Costo, Thông Dao, Jean-Pierre Pelage, Jérôme Dumortier, Francesco Giammarile, Pierre-Jean Valette, Nadia Ghazzar, Olivier Pellerin, Julien Taieb, Pierre Weinmann, Alexandra Heurgue- Berlot, Claude Marcus, Daniele Sommacale, Maria-Angéla Castilla-Lièvre, Sophie Maitre, Lysiane Marthey
Publikováno v:
Clinical Therapeutics
Clinical Therapeutics, Elsevier, 2021, 43 (7), pp.1201-1212. ⟨10.1016/j.clinthera.2021.04.018⟩
Clinical Therapeutics, Elsevier, 2021, 43 (7), pp.1201-1212. ⟨10.1016/j.clinthera.2021.04.018⟩
International audience; Purpose: The SARAH (Sorafenib Versus Radioembolization in Advanced Hepatocellular Carcinoma) trial (ClinicalTrials.gov Identifier NCT01482442) did not show a significant survival benefit for patients treated with transarterial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::752ee1076b1158138d47fee4c66562c1
https://hal.archives-ouvertes.fr/hal-03617593
https://hal.archives-ouvertes.fr/hal-03617593
Publikováno v:
International Journal of Pharmaceutics. 494:329-336
Control of chemotherapies preparations are now an obligation in France, though analytical control is compulsory. Several methods are available and none of them is presumed as ideal. We wanted to compare them so as to determine which one could be the
Autor:
Hélène Gilbert, Claire Hassenfratz, Hervé Garreau, Alain Ducos, Catherine Larzul, Thierry Tribout, Christophe Bazin, J. P. Bidanel, Sandrine Schwob, Denis Milan, Jean Pierre Bidanel, Parsaoran Silalahi, Marie-José Mercat, Juliette Riquet, Alain Bouquet, Laurianne Canario
Publikováno v:
50. journées de la recherche porcine
50. Journées de la Recherche Porcine
50. Journées de la Recherche Porcine, Feb 2018, Paris, France
50. Journées de la Recherche Porcine, Institut du Porc (IFIP). FRA., Feb 2018, Paris, France
INRA Productions Animales
INRA Productions Animales, Paris: INRA, 2020, 33 (1), pp.1-16. ⟨10.20870/productions-animales.2020.33.1.3092⟩
50. Journées de la Recherche Porcine
50. Journées de la Recherche Porcine, Feb 2018, Paris, France
50. Journées de la Recherche Porcine, Institut du Porc (IFIP). FRA., Feb 2018, Paris, France
INRA Productions Animales
INRA Productions Animales, Paris: INRA, 2020, 33 (1), pp.1-16. ⟨10.20870/productions-animales.2020.33.1.3092⟩
International audience; Cette synthèse fait le point sur les principales évolutions de l’amélioration génétique du porc en France depuis la loi sur l’élevage de 1966. Elle évoque rapidement les 20 premières années, qui ont fait l’objet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21fe7d014a686b1e9d45d3d7b7767a9f
https://hal.archives-ouvertes.fr/hal-01723929
https://hal.archives-ouvertes.fr/hal-01723929
Autor:
Valérie Vilgrain, Helena Pereira, Eric Assenat, Boris Guiu, Alina Diana Ilonca, Georges-Philippe Pageaux, Annie Sibert, Mohamed Bouattour, Rachida Lebtahi, Wassim Allaham, Hélène Barraud, Valérie Laurent, Elodie Mathias, Jean-Pierre Bronowicki, Jean-Pierre Tasu, Rémy Perdrisot, Christine Silvain, René Gerolami, Olivier Mundler, Jean-Francois Seitz, Vincent Vidal, Christophe Aubé, Frédéric Oberti, Olivier Couturier, Isabelle Brenot-Rossi, Jean-Luc Raoul, Anthony Sarran, Charlotte Costentin, Emmanuel Itti, Alain Luciani, René Adam, Maïté Lewin, Didier Samuel, Maxime Ronot, Aurelia Dinut, Laurent Castera, Gilles Chatellier, Elisabeth Delhom - Christol, Alina D Ilonca, Julie Lonjon, Mohamed Abdel-Rehim, Arnaud Dieudonné, Christophe Bazin, Carine Chagneau-Derrode, Patrick Borentain, Antoine Bouvier, Laurent Vervueren, Julia Chalaye, Hicham Kobeiter, Julien Edeline, Etienne Garin, Yan Rolland, Isabelle Archambeaud, Thomas Eugene, Eric Frampas, Christophe Cassinotto, Martine Guyot, Jean-Baptiste Hiriart, Bruno Lapuyade, Julien Vergniol, Philippe Bachellier, Julien Detour, Bernard Duclos, Michel Greget, Francois Habersetzer, Alessio Imperiale, Philippe Merle, Agnès Rode, Julie Morvan, Eric Nguyen-Khac, Thierry Yzet, Guillaume Baudin, Patrick Chevallier, Abakar Mahamat, Thierry Piche, Micheline Razzouk, Patrick Hillon, Romaric Loffroy, Michel Toubeau, Julie Vincent, Gabriele Barabino, Nadia Bouarioua, Muriel Cuilleron, Marie Ecochard, Nathalie Prevot-Bitot, Vincent Leroy, Julie Roux, Christian Sengel, Valérie Bourcier, Nathalie Ganne-Carrie, Olivier Seror, Sylvie Costo, Thông Dao, Jean-Pierre Pelage, Jérôme Dumortier, Francesco Giammarile, Pierre-Jean Valette, Nadia Ghazzar, Olivier Pellerin, Julien Taieb, Pierre Weinmann, Alexandra Heurgue-Berlot, Claude Marcus, Daniele Sommacale, Maria-Angéla Castilla-Lièvre, Sophie Maitre, Lysiane Marthey
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2017, 18 (12), pp.1624-1636. ⟨10.1016/S1470-2045(17)30683-6⟩
Lancet Oncology, Elsevier, 2017, 18 (12), pp.1624-1636. ⟨10.1016/S1470-2045(17)30683-6⟩
Summary Background Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of selective internal radiotherapy (SIRT) with yttrium-90 ( 90 Y) resin mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37960b5209b2b33f51aee9e80e06e797
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01727346
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01727346
Publikováno v:
Toxicologie Analytique et Clinique
Toxicologie Analytique et Clinique, Elsevier, 2015, 27 (2), pp.81--87. ⟨10.1016/j.toxac.2015.01.004⟩
Toxicologie Analytique et Clinique, 2015, 27 (2), pp.81--87. ⟨10.1016/j.toxac.2015.01.004⟩
Toxicologie Analytique et Clinique, Elsevier, 2015, 27 (2), pp.81--87. ⟨10.1016/j.toxac.2015.01.004⟩
Toxicologie Analytique et Clinique, 2015, 27 (2), pp.81--87. ⟨10.1016/j.toxac.2015.01.004⟩
Summary Screening for cyclic antidepressants compounds is a classical toxicology test. Immunological tests are badly known, especially concerning their sensivity and interferences. To investigate which molecules could produce false positive results f
Autor:
Sebastien Naude, Jean-Pierre Bronowicki, Marc Bourlière, Hervé Perrier, Jean-Luc Raoul, Christophe Bazin, Olivier Monnet, Olivier Bayle, Xavier Adhoute, B. Pol, Patrick Beaurain, Gaelle Le Folgoc, Guillaume Penaranda, Paul Castellani
Publikováno v:
Journal of Hepatology
Journal of Hepatology, Elsevier, 2015, 62 (4), pp.855-862. ⟨10.1016/j.jhep.2014.11.014⟩
Journal of Hepatology, Elsevier, 2015, 62 (4), pp.855-862. ⟨10.1016/j.jhep.2014.11.014⟩
International audience; BACKGROUND & AIMS:Transarterial chemoembolization (TACE) is the standard of care for intermediate stage hepatocellular carcinoma (HCC) and it is the most commonly used treatment for HCC worldwide. However, no prognostic indice
Publikováno v:
Annales Pharmaceutiques Françaises. 72:33-40
Summary Post-production analytic control of chemotherapies preparations remains a challenge for hospital pharmacists. Indeed, to be feasible, this control needs to be reliable, fast and easy to implement and to use on real life. This is particularly